Healthy Clinical Trial
— SPECTRAOfficial title:
Interindividual Variability in Cognitive Aging: Neural Mechanisms, Reserve Processes and Malleability of Neuroprotective Processes.
Aging leads to cognitive changes that affect memory, particularly episodic retrieval. These impairments are detrimental to seniors' quality of life. Cognitive trainings are of great interest to the scientific community because they improve cognition in older people, and produce structural and functional changes likely to provide neuroprotection. Identifying the brain changes induced by cognitive training could therefore provide a better understanding of the neuroplastic processes of the aging brain. Some training programs aim to improve key processes underlying cognitive functioning to lead to transfer, but these most often target working memory or processing speed. Our aim is to understand the brain changes associated with a training program targeting episodic retrieval, and likely to engage a core network for memory, including the anterior hippocampus. 60 healthy older adults will be randomly divided into two groups; one receiving a training based on the Episodic Specificity Induction (ESI) - a manipulation based on a well-established police interviewing technique thought to target and facilitate episodic construction; the other receiving a control training consisting of recalling pairs of words and images. Before and after training, behavioural and brain measures will be taken. Behavioural measures will be taken during recall, recognition, and problem solving tasks. These tasks will be completed once in the ESI condition (after one ESI) and once in the NoESI condition (after a general thoughts interview). Measures of brain activation as well as static and dynamic functional connectivity (SFC & DFC) will be taken using magnetic resonance imaging (MRI) during a recognition task. For behavioural measures, higher pre-training performance should be observed in the ESI than in the NoESI condition, and pre-to-post-training improvement should be observed only after the ESI training, especially in the NoESI condition. For brain measures, ESI training should decrease activation of the task network targeted by training, reflecting an increase in efficiency. ESI training should also increase the SFC of the task network and reduce its connectivity with the cognitive control network, suggesting more automated processing. Finally, ESI training should increase DFC by increasing the speed of transition between the networks associated with the two phases of episodic retrieval: the construction phase and the elaboration phase.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | February 2, 2024 |
Est. primary completion date | February 2, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 85 Years |
Eligibility | Inclusion Criteria: - French-speaking - Right-handed - Sufficient visual and auditory acuity to undergo neuropsychological tests and to do the interventions. - Sufficient delayed recall score above the education-adjusted cut-offs (=9 for 16+ years of education; =5 for 8-15 years of education; =3 for 0-7 years of education) at the Logical Memory test (Wechsler Memory Scale, maximum score 25). Exclusion Criteria: - A score bellow the education-adjusted cut-offs at the MoCA ( <24 for >12 years of education; <23 for = or <12 years of education) - Answer 'Yes' to the two following questions: "Do you feel like your memory is becoming worse?" "Does this worry you?" (to exclude subjective cognitive decline). - The presence of a disease or injury of the central nervous system: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, subdural hematoma (past or current), subarachnoid haemorrhage (past or current), primary cerebral tumour or cerebral metastases, epilepsy (current), dementia or another neurodegenerative disease, and other rarer brain illnesses. - Symptomatic stroke within the previous year. - Alcoholism or substance abuse - History of intracranial surgery. - Major surgery within last 2 months. - General anesthesia in the past 6 months. - Serious comorbid condition that, in the opinion of the study investigator, is likely to result in death within a year. - Major depression or anxiety. - Schizophrenia or other major psychiatric disorder (e.g., bipolar disorder). - Individuals where French is not sufficiently proficient for clinical assessment and neuropsychological testing. - Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure. - Plans on moving outside the province within the next 2 months. |
Country | Name | City | State |
---|---|---|---|
Canada | CRIUGM | Montréal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal | Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council, Canada |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Effect of moderators: Sex. | Male vs Female on the intervention effect | In the week preceding the start of the intervention (PRE) | |
Other | Effect of moderators: Cognitive reserve proxies. | Scores on the reserve-proxy questionnaire (from Rami L, Valls-Pedret C, Bartres-Faz D, et al. 2011) on the intervention effect | In the week preceding the start of the intervention (PRE) | |
Primary | Changes in the number of correct specific detail recall (nearest transfer outcome) | For the free recall task, verbal recall will be recorded and transcribed. Recalled details will be rated as specific according to the Autobiographical Interview procedure developed by Levine et al (2002). The number of specific details recalled will be measured, and the accuracy of these details will be evaluated. The number of correct specific details will be calculated by subtracting the incorrect specific details from the recalled specific details. | In the week preceding the start of the intervention (PRE) both in the ESI and the NoESI condition; In the week of the last intervention session (POST) both in the ESI and the NoESI condition | |
Secondary | Brain function: Memory related activation | Functional activations. Functional images are acquired on a 3.0T Siemens Prisma scanner using 32-channel head coil and Simultaneous multi-slice (SMS) echo planar imaging (EPI) sequence: parallel imaging parameters: multiband factor = 3 with GRAPPA (R) factors 2; TR = 0.910 s; TE = 20 ms; flip angle 56°; voxels 2.5 mm³; 57 slices; FOV: 200; acquisition matrix: 80 x80 | In the week preceding the start of the intervention (PRE); In the week of the last intervention session (POST) | |
Secondary | Brain function: Memory related activation (Static functional connectivity) | Static functional connectivity. Functional images are acquired on a 3.0T Siemens Prisma scanner using 32-channel head coil and Simultaneous multi-slice (SMS) echo planar imaging (EPI) sequence: parallel imaging parameters: multiband factor = 3 with GRAPPA (R) factors 2; TR = 0.910 s; TE = 20 ms; flip angle 56°; voxels 2.5 mm³; 57 slices; FOV: 200; acquisition matrix: 80 x80 | In the week preceding the start of the intervention (PRE); In the week of the last intervention session (POST) | |
Secondary | Brain function: Memory related activation (Dynamic functional connectivity) | Dynamic functional connectivity. Functional images are acquired on a 3.0T Siemens Prisma scanner using 32-channel head coil and Simultaneous multi-slice (SMS) echo planar imaging (EPI) sequence: parallel imaging parameters: multiband factor = 3 with GRAPPA (R) factors 2; TR = 0.910 s; TE = 20 ms; flip angle 56°; voxels 2.5 mm³; 57 slices; FOV: 200; acquisition matrix: 80 x80 | In the week preceding the start of the intervention (PRE); In the week of the last intervention session (POST) | |
Secondary | Changes in the measure of discriminability (d') (near transfer outcome) - fMRI | For the fMRI recognition task, a d' measure will be calculated using the following formula: d' = z(hit rate) - z(false alarm rate) | In the week preceding the start of the intervention (PRE); In the week of the last intervention session (POST) | |
Secondary | Changes in the number of relevant steps produced (far transfer outcome) | For the problem solving task, verbal production of steps will be recorded and transcribed, and the number of relevant steps will be computed using the same procedure as Madore & Schacter (2014) | In the week preceding the start of the intervention (PRE) both in the ESI and the NoESI condition; In the week of the last intervention session (POST) both in the ESI and the NoESI condition | |
Secondary | Changes in the measure of discriminability (d') (near transfer outcome) | For the recognition task, a d' measure will be calculated using the following formula: d' = z(hit rate) - z(false alarm rate) | In the week preceding the start of the intervention (PRE) both in the ESI and the NoESI condition; In the week of the last intervention session (POST) both in the ESI and the NoESI condition |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |